Medi Caps
29.35
+0.01(+0.03%)
Market Cap₹36.61 Cr
PE Ratio-8.38
IndustryHealthcare
Company Performance:
1D+0.03%
1M+23.32%
6M-25.49%
1Y-32.09%
5Y-27.71%
View Company Insightsright
More news about Medi Caps
05Aug 25
Medi-Caps Limited Re-appoints Dharmendra Solanki as Independent Director for Second Term
Medi Caps Limited has announced the re-appointment of Dharmendra Solanki as Non-Executive Independent Director for a second five-year term, from February 5, 2026, to February 4, 2031, subject to shareholder approval. Solanki, with 27 years of experience in Accounts, Finance, and Taxation, holds Commerce degrees from Vikram University. The company also approved financial results, scheduled the 42nd AGM for September 18, 2025, and appointed Joshi Sahay and Company as Secretarial Auditor for a five-year term.
 no imag found
Medi Caps
29.35
+0.01
(+0.03%)
1 Year Returns:-32.09%
Industry Peers
Sun Pharmaceutical
1,624.50
(-3.31%)
Divis Laboratories
6,366.00
(-0.20%)
Torrent Pharmaceuticals
4,102.00
(-1.09%)
Dr Reddys Laboratories
1,308.40
(-1.70%)
Lupin
2,308.70
(-1.40%)
Cipla
1,289.00
(-1.29%)
Mankind Pharma
2,282.70
(-0.44%)
Zydus Life Science
925.45
(-2.21%)
Aurobindo Pharma
1,428.00
(-0.52%)
Alkem Laboratories
5,518.50
(-0.04%)